Stephen Sykes

Medicine & Life Sciences

1. Hematopoietic Stem Cells 100%
2. Acute Myeloid Leukemia 91%
3. Leukemia 60%
4. Poly(ADP-ribose) Polymerase Inhibitors 38%
5. Mutation 37%
6. Hematopoiesis 34%
7. Acetylation 33%
8. Homologous Recombination 30%
9. DNA 30%
10. Apoptosis 30%
11. Neoplasms 27%
12. Mechanistic Target of Rapamycin Complex 2 26%
13. Stem Cells 26%
14. Hematopoietic Stem Cell Mobilization 26%
15. Bone Marrow 24%
16. DNA Repair 23%
17. Myeloid Cells 22%
18. Myelodysplastic Syndromes 22%
19. Mechanistic Target of Rapamycin Complex 1 21%
20. DNA Damage 20%
21. Fanconi Anemia 19%
22. Synthetic Lethal Mutations 19%
23. Fanconi Anemia Complementation Group D2 Protein 17%
24. Identity Crisis 16%
25. Cell Biology 16%
26. Cell Cycle 15%
27. Wnt Signaling Pathway 15%
28. Genes 15%
29. Megakaryocytes 13%
30. Interleukin-27 13%
31. Protein Kinase C-epsilon 13%
32. Myelopoiesis 13%
33. Reactive Oxygen Species 13%
34. Sirolimus 13%
35. Immunoglobulin Class Switching 13%
36. Clonal Evolution 12%
37. Cell Survival 12%
38. Hematopoietic System 12%
39. Haploinsufficiency 11%
40. BRCA1 Protein 11%
41. Hypoxia-Inducible Factor 1 11%
42. Unfolded Protein Response 11%
43. Oncogenes 11%
44. Heparitin Sulfate 11%
45. Myeloid Leukemia 11%
46. Peroxisome Proliferator-Activated Receptors 11%
47. Cell Differentiation 11%
48. Immunoglobulin Isotypes 10%
49. Post Translational Protein Processing 10%
50. Lysine 10%